290 is a clinical research site located in Seattle, Washington, United States.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
290 has participated in 1 clinical trials.
Therapeutic areas: Crohn Disease.
Sponsors: UCB BIOSCIENCES GmbH.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
290 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
290 has 1 clinical trials on record. Their work covers Crohn Disease.
290 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.